LARGE CELL NEUROENDOCRINE CARCINOMA
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough cancers
Disease control OngoingThis early-phase trial tests an investigational drug called ABBV-706, alone or combined with other drugs, in about 288 adults with advanced solid tumors like small cell lung cancer, high-grade brain tumors, and neuroendocrine cancers. The main goals are to check safety, find the …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo attack on stubborn cancers shows promise in early trial
Disease control OngoingThis phase II trial tests whether combining the immunotherapy drug nivolumab with the chemotherapy drug temozolomide can shrink tumors in people with small-cell lung cancer that has returned or not responded to treatment, or advanced neuroendocrine tumors. About 55 participants w…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC